ANXA2 and urothelial carcinoma: therefore, the expression of AnxA2 protein was compared by immunoblot analysis in lysates prepared from RT4 and T24 bladder cancer cell lines, which were derived from a grade I urothelial carcinoma (also called papilloma) patient [35] and poorly differentiated (grade III) bladder carcinoma with metastatic profile [36], respectively.